Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 72 results for "devang mehta"

Suven Life Sciences could be a dark horse: Devang Mehta

Typically, it is a pharma stock which enjoys very high margins. In addition, it has a huge monetisation opportunity for one of its molecule — SUVN-502. Economic Times, 3 days ago
Suven Life could be a dark horse: Devang Mehta Economic Times, 3 days ago

Avoid VIP Industries, prefer Titan Company: Devang Mehta

Devang Mehta of Anand Rathi Financial Services recommends avoiding VIP Industries and prefers Titan Company.
 Money Control2 days ago

Look at CARE, target Rs 2100-2200: Devang Mehta

Devang Mehta of Anand Rathi Financial Services is of the view that CARE may test Rs 2100-2200.
 Money Control1 week ago

Buy ICICI Bank, says Devang Mehta

Devang Mehta of Anand Rathi Financial Services recommends buying ICICI Bank.
 Money Control2 weeks ago Buy ITC for long term: Devang Mehta  Money Control2 weeks ago Granules India may test Rs 1000: Devang Mehta  Money Control2 months ago HDFC Bank may test Rs 1100-1120: Devang Mehta  Money Control2 months ago

Expect polarisation in markets to continue: Devang Mehta, Anand Rathi Financial Services

Comments are moderated and will be allowed if they are about the topic and not abusive. Characters remaining ( 1500 ) To post this comment you must Log In/Connect with: Indiatimes Network or Fill in your details: Will be displayed Will not be displayed Will ...
 Economic Times3 weeks ago Market witnessing sectoral rotation currently: Devang Mehta, Anand Rathi Financial Services  Economic Times1 month ago

Keep LT in portfolio, says Devang Mehta

According to Devang Mehta of Anand Rathi Financial Services, Larsen and Toubro would remain the top pick and it has to be a portfolio stock for a period of two or three years.
 Money Control1 month ago ING Vysya a better pick than Kotak Mahindra currently: Devang Mehta, Anand Rathi Financial Services  Economic Times2 months ago

Bullish on Ipca Labs, Natco Pharma & Granules India in midcap pharma space: Devang Mehta

"We currently like a lot of midcap pharma companies also. Some of them have underperformed in the market for their own reasons however." In a chat with ET Now, Devang Mehta, Senior VP & Head Equities Sales of Anand Rathi Financial Services, shares his views ...
 Economic Times1 month ago

Prefer REC, PFC, MM Fin, LIC Housing: Devang Mehta

Devang Mehta of Anand Rathi Financial Services is of the view that one can prefer Rural Electrification Corporation, Power Finance Corporation, LIC Housing Finance and Mahindra Mahindra Financial Services.
 Money Control1 month ago

Cautious on banks in short-term: Sudarshan Sukhani

In an interview to CNBC-TV18 Sudarshan Sukhani of s2analytics, Devang Mehta of Anand Rathi
 INooz1 month ago Mkt momentum on upside, may surprise going ahead: Sukhani  Money Control2 months ago Market volatility to continue; upbeat on banks: Experts  Moneycontrol.com2 weeks ago Cautious on banks in short-term, says Sukhani  Money Control1 month ago

We Are In A Strong Structural Bull Run

A hardcore follower of fundamentals and a firm believer of the India growth story, Devang Mehta has in-depth expertise on market strategy and investment advisory. Presently, Head of Equity Advisory at Anand Rathi Financial Services, this Market ...
 Afternoon Despatch & Courier2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less